| Bioactivity | Methylbenactyzium Bromide is a muscarinic acetylcholine receptor (mAChR) inhibitor. |
| Target | mAChR |
| Invitro | Methylbenactyzium Bromide is a muscarinic acetylcholine receptor (mAChR) inhibitor[1]. Methylbenactyzium bromide has been used as a spasmolytic for the treatment of gastrointestinal ulcer[2]. |
| Name | Methylbenactyzium Bromide |
| CAS | 3166-62-9 |
| Formula | C21H28BrNO3 |
| Molar Mass | 422.36 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Bhattacharjee AK, et al. Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods. Bioorg Med Chem. 2013 May 1;21(9):2651-62. [2]. Nishikawa M, et al. Analysis of methylbenactyzium bromide in human urine by thin-layer chromatography and pyrolysis gas chromatography. Forensic Sci Int. 1991 Mar;49(2):197-203. |